Author Details

Balakhonova, T V

Issue Section Title File
Vol 80, No 7 (2008) Editorial article Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis
Vol 81, No 6 (2009) Editorial article Affection of target organs in hypertensive patients with and without metabolic syndrome
Vol 81, No 9 (2009) Editorial article Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment
Vol 83, No 8 (2011) Editorial article Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins
Vol 83, No 9 (2011) Editorial article Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale
Vol 83, No 12 (2011) Editorial article Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications
Vol 84, No 9 (2012) Editorial article Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events
Vol 84, No 9 (2012) Editorial article Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: Two-year follow-up results
Vol 91, No 9 (2019) Editorial article Comparative efficacy and safety of enoxaparin followed by warfarin and rivaroxaban monotherapy in the treatment of venous thrombosis in patients after intracardiac catheter interventions PDF
(Rus)